Certara announced it has signed a definitive agreement to acquire Chemaxon, a leading provider of cheminformatics software. The transaction is expected to close in the second half of 2024, subject to regulatory approval and other customary closing conditions. Chemaxon develops leading software products for chemical structure drawing, property prediction, search, and analysis. Used by research scientists globally, Chemaxon software helps to digitize the design, make, test and analyze lifecycle to discover the best new chemical leads. Certara and Chemaxon have had a long-term partnership spanning ten years. In 2024, Chemaxon is expected to generate software revenue greater than $20M. Chemaxon has a revenue growth profile comparable to Certara’s software business and is expected to reach an adjusted EBITDA margin near Certara’s corporate average by the end of 2025.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CERT:
- Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
- Certara price target lowered to $16 from $18 at Barclays
- Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software
- Certara launches next-generation CoAuthor generative AI software
- Certara appoints Anhalt as CHRO, Corcoran as General Counsel